ascendis pharma glp-1 Weight Loss Florida Novo inks Ascendis deal to

Wegovy package insert / prescribing information for healthcare professionals

The authors connect this to something known as the rate hypothesis in addiction research: the faster a substance hits the brain, the stronger and more rewarding it feels

Iwasaki Y, Sendo M, Dezaki K, Hira T, Sato T, Nakata M, et al

Corbion is excited to sponsor Food Business News upcoming webinar on the Trends & Innovations: Bracing for the Impact of GLP-1s." As GLP-1 adoption continues to grow, food and beverage manufacturers are watching closely to understand how shifting consumer behaviors may influence product choices, category performance, and future innovation

Although these mechanisms have been exploited to facilitate weight loss, these medications have also been indicated for patients with cardiovascular or renal diseases, all of which have caused a recent drastic rise in prescribing GLP-1 RAs